Education
Medical School
Yale University School of Medicine (2010)
Internship
Memorial Sloan-Kettering Cancer Center (2011), Transitional Year
Residency
Memorial Sloan Kettering Cancer Center (2015), Radiation Oncology

Research Interest
  • Bladder cancer
  • Prostate cancer

Publications
Bony structure enhanced synthetic CT generation using Dixon sequences for pelvis MR-only radiotherapy
Liang X, Yen A, Bai T, Godley A, Shen C, Wu J, Meng B, Lin MH, Medin P, Yan Y, Owrangi A, Desai N, Hannan R, Garant A, Jiang S, Deng J Medical physics 2023 Dec 50 7368-7382
Prostate Cancer, Version 4.2023
Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, Bryce A, Chapin B, Cheng HH, D’Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Guzzo T, Ippolito JE, Kuettel MR, Lang JM, Lotan T, McKay RR, Morgan T, Netto G, Pow-Sang JM, Reiter R, Roach M, Robin T, Rosenfeld S, Shabsigh A, Spratt D, Teply BA, Tward J, Valicenti R, Wong JK, Shead DA, Snedeker J, Freedman-Cass DA JNCCN Journal of the National Comprehensive Cancer Network 2023 Oct 21 1067-1096
Organ sparing treatment for penile cancer using a 3D-printed high-dose-rate brachytherapy applicator
Lee HH, Chiu TD, Hrycushko B, Xiong Z, Hudak S, Woldu S, Mauck R, Corwin T, Meng X, Margulis V, Desai N, Folkert MR, Garant A Brachytherapy 2023 Sep 22 580-585
Quality Metric to Assess Adequacy of Hydrogel Rectal Spacer Placement for Prostate Radiation Therapy and Association of Metric Score With Rectal Toxicity Outcomes
Grossman CE, Folkert MR, Lobaugh S, Desai NB, Kollmeier MA, Gorovets D, McBride SM, Timmerman RD, Zhang Z, Zelefsky MJ Advances in Radiation Oncology 2023 Jul 8
Passing the Kool-Aid Point: mRNA Expression–Based Risk Classifiers in Localized Prostate Cancer Treatment Decision Making
Desai NB, Dal Pra A, Chua ML, Berlin A International Journal of Radiation Oncology Biology Physics 2023 Jul 116 530-532
Preliminary Evaluation of PTV Margins for Online Adaptive Radiation Therapy of the Prostatic Fossa
Morgan HE, Wang K, Yan Y, Desai N, Hannan R, Chambers E, Cai B, Lin MH, Sher DJ, Wang J, Wang AZ, Jiang S, Timmerman R, Park C“, Garant A Practical Radiation Oncology 2023 Jul 13 e345-e353
Optimizing Palliative Focal Radiation Therapy Dose in Cutaneous T-Cell Lymphoma: How Low Can You Go?
Patel AM, West L, Atluri PS, Yi SF, Rizvi S, Geethakumari PR, Awan FT, Chen W, Shah JL, Desai NB, Goff HW, Kumar KA Practical Radiation Oncology 2023 Mar 13 e192-e199
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer after Radical Prostatectomy: The SALV-ENZA Trial
Tran PT, Lowe K, Tsai HL, Song DY, Hung AY, Hearn JW, Miller S, Proudfoot JA, Deek MP, Phillips R, Lotan T, Paller CJ, Marshall CH, Markowski M, Dipasquale S, Denmeade S, Carducci M, Eisenberger M, Deweese TL, Orton M, Deville C, Davicioni E, Liauw SL, Heath EI, Greco S, Desai NB, Spratt DE, Feng F, Wang H, Beer TM, Antonarakis ES Journal of Clinical Oncology 2023 Feb 41 1307-1317
NCCN GUIDELINES® INSIGHTS: Prostate Cancer, Version 1.2023: Featured Updates to the NCCN Guidelines
Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, Bryce A, Chapin B, Cheng HH, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Guzzo T, Ippolito JE, Kuettel MR, Lang JM, Lotan T, McKay RR, Morgan T, Netto G, Pow-Sang JM, Reiter R, Roach M, Robin T, Rosenfeld S, Shabsigh A, Spratt D, Teply BA, Tward J, Valicenti R, Wong JK, Berardi RA, Shead DA, Freedman-Cass DA JNCCN Journal of the National Comprehensive Cancer Network 2022 Dec 20 1288-1298
Enrichment of “Cribriform” morphologies (intraductal and cribriform adenocarcinoma) and genomic alterations in radiorecurrent prostate cancer
Shah RB, Palsgrove DN, Desai NB, Gagan J, Mennie A, Raj G, Hannan R Modern Pathology 2022 Oct 35 1468-1474